ZIVO BIOSCIENCE, INC. (ZIVO) Total liabilities 2015–2024
ZIVO BIOSCIENCE, INC. (ZIVO) total liabilities at each fiscal year-end, per SEC filings.
$2.2MFY2024 · since FY2015: $9.6M → $2.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $2.2M | -21.9% |
| FY2023 | $2.8M | +29.4% |
| FY2022 | $2.1M | -27.6% |
| FY2021 | $2.9M | -74.4% |
| FY2020 | $11.5M | +32.4% |
| FY2019 | $8.7M | -61.6% |
| FY2018 | $22.7M | +36.4% |
| FY2017 | $16.6M | +15.9% |
| FY2016 | $14.4M | +50.0% |
| FY2015 | $9.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ZIVO financial trends
ZIVO RevenueZIVO Net incomeZIVO Net marginZIVO Gross profitZIVO Gross marginZIVO Operating incomeZIVO Operating marginZIVO Operating cash flowZIVO Free cash flowZIVO Capital expendituresZIVO Return on equityZIVO Stock buybacksZIVO Dividends paidZIVO Total assetsZIVO Shareholders’ equityZIVO overview →